Katarzyna Jastrzebska1,2, Anna Florczak1,2, Kamil Kucharczyk1, Yinnan Lin3, Qin Wang3, Andrzej Mackiewicz1,4,5, David L Kaplan3, Hanna Dams-Kozlowska1,5. 1. Chair of Medical Biotechnology, Poznan University of Medical Sciences, 61-688 Poznan, Poland. 2. NanoBioMedical Centre, Adam Mickiewicz University, 61-614 Poznan, Poland. 3. Biomedical Engineering Department, Tufts University, Medford, MA 02155, USA. 4. BioContract Sp. z o.o., 61-051 Poznan, Poland. 5. Department of Diagnostics & Cancer Immunology, Greater Poland Cancer Centre, 61-688 Poznan, Poland.
Abstract
AIM: Analysis of the properties and chemotherapeutics delivery potential of spheres made of bioengineered spider silks MS1 and MS2. MATERIALS & METHODS: MS1 and MS2 derived from Nephila clavipes dragline silks - MaSp1 and MaSp2, respectively - formed spheres that were compared in terms of physicochemical properties, cytotoxicity and loading/release of chemotherapeutics. RESULTS: MS2 spheres were more dispersed, smaller, of solid core, of higher beta-sheet structure content, and of opposite (negative) charge than MS1 spheres. Preloaded MS2 showed greater applicability for mitoxantrone, while postloaded for etoposide delivery compared with MS1 spheres. However, MS1 spheres were a better choice for doxorubicin delivery than MS2. CONCLUSION: Bioengineered silks can be tailored to develop a system with optimal drug loading and release properties.
AIM: Analysis of the properties and chemotherapeutics delivery potential of spheres made of bioengineered spider silks MS1 and MS2. MATERIALS & METHODS: MS1 and MS2 derived from Nephila clavipes dragline silks - MaSp1 and MaSp2, respectively - formed spheres that were compared in terms of physicochemical properties, cytotoxicity and loading/release of chemotherapeutics. RESULTS: MS2 spheres were more dispersed, smaller, of solid core, of higher beta-sheet structure content, and of opposite (negative) charge than MS1 spheres. Preloaded MS2 showed greater applicability for mitoxantrone, while postloaded for etoposide delivery compared with MS1 spheres. However, MS1 spheres were a better choice for doxorubicin delivery than MS2. CONCLUSION: Bioengineered silks can be tailored to develop a system with optimal drug loading and release properties.
Entities:
Keywords:
MaSp1; MaSp2; bioengineered spider silk; biomaterial; biomedicine; cancer therapy; chemotherapeutics; drug carrier; spheres
Authors: Alexander N Mitropoulos; Giovanni Perotto; Sunghwan Kim; Benedetto Marelli; David L Kaplan; Fiorenzo G Omenetto Journal: Adv Mater Date: 2013-12-12 Impact factor: 30.849
Authors: Aniela Heidebrecht; Lukas Eisoldt; Johannes Diehl; Andreas Schmidt; Martha Geffers; Gregor Lang; Thomas Scheibel Journal: Adv Mater Date: 2015-02-16 Impact factor: 30.849
Authors: F Philipp Seib; Gregory T Jones; Jelena Rnjak-Kovacina; Yinan Lin; David L Kaplan Journal: Adv Healthc Mater Date: 2013-04-26 Impact factor: 9.933
Authors: John G Hardy; Jose Guillermo Torres-Rendon; Aldo Leal-Egaña; Andreas Walther; Helmut Schlaad; Helmut Cölfen; Thomas R Scheibel Journal: Materials (Basel) Date: 2016-07-11 Impact factor: 3.623
Authors: Anna Florczak; Tomasz Deptuch; Anna Lewandowska; Karolina Penderecka; Elzbieta Kramer; Andrzej Marszalek; Andrzej Mackiewicz; Hanna Dams-Kozlowska Journal: J Nanobiotechnology Date: 2020-12-01 Impact factor: 10.435
Authors: Kamil Kucharczyk; Marek Weiss; Katarzyna Jastrzebska; Magdalena Luczak; Arkadiusz Ptak; Maciej Kozak; Andrzej Mackiewicz; Hanna Dams-Kozlowska Journal: Int J Nanomedicine Date: 2018-07-20